Knowledge Diffusion News Today : Breaking News, Live Updates & Top Stories | Vimarsana

UNESCO Silk Roads Youth Research Grant – Reinforcing the Capacity and Contribution of Young Researchers to the Silk Roads

J&K ranked at bottom in NITI Aayog’s Innovation Index J&K ranked at bottom in NITI Aayog’s Innovation Index Nishikant Khajuria JAMMU, Jan 20: Jammu Kashmir has been ranked at the bottom in the NITI Aayog’s Innovation Index, released today, covering all the States and Union Territories across India. Among the Union Territories, Delhi tops the ranking in all the groups , followed by Chandigarh whereas Lakshadweep and Jammu Kashmir occupy the last two positions in the group respectively. Karnataka, Maharashtra, Tamil Nadu, Telangana and Kerala have been ranked as the top five States...

Karnataka retains top spot on innovation index  Skilled human resource, ease of doing business, legalities, knowledge dissemination, health and education are some of the parameters considered to decide the ranking. Share Via Email   |  A+A A- By Express News Service BENGALURU: Karnataka has retained the top position in the innovation index for a second year in a row, a pointer to its strength in maintaining the leadership position. The state’s innovation score of 42.5 was way above the average score of 25.35 among the major states. Maharashtra was in second place with a score of 38...

Researchers use AI platform to identify best combination of available therapies against COVID-19. A team of researchers from the National University of Singapore (NUS) has utilized a ground-breaking artificial intelligence (AI) platform to derive an optimal combination of available therapies against SARS-CoV-2, the cause of COVID-19. Their results showed that the optimal drug therapy was a combination of the drugs remdesivir, ritonavir, and lopinavir at specific doses. Remdesivir is a broad antiviral medication that was recently approved by the United States Food and Drug Administration as a ...

Using AI to find optimal combination of available therapies against SARS-CoV-2 A team of researchers from the National University of Singapore (NUS) has utilized a ground-breaking artificial intelligence (AI) platform to derive an optimal combination of available therapies against SARS-CoV-2, the cause of COVID-19. Their results showed that the optimal drug therapy was a combination of the drugs remdesivir, ritonavir, and lopinavir at specific doses. Remdesivir is a broad antiviral medication that was recently approved by the United States Food and Drug Administration as a treatment for COVID...